Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Advancing technologies for accelerated drug development.

Albert P Li1

  • 1PHASE-1 Molecular Toxicology, 2904 Rodeo Park Drive East, Santa Fe, NM 87505, USA. ali@phase1tox.com

Drug Discovery Today
|March 14, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Developing a Screening Strategy to Identify Hepatotoxicity and Drug Interaction Potential of Botanicals.

Journal of dietary supplements·2024
Same author

Advances in Animal Models and Cutting-Edge Research in Alternatives: Proceedings of the Third International Conference on 3Rs Research and Progress, Vishakhapatnam, 2022.

Alternatives to laboratory animals : ATLA·2023
Same author

Permeabilized Cryopreserved Human Hepatocytes as an Exogenous Metabolic System in a Novel Metabolism-Dependent Cytotoxicity Assay for the Evaluation of Metabolic Activation and Detoxification of Drugs Associated with Drug-Induced Liver Injuries: Results with Acetaminophen, Amiodarone, Cyclophosphamide, Ketoconazole, Nefazodone, and Troglitazone.

Drug metabolism and disposition: the biological fate of chemicals·2021
Same author

Messenger RNA Expression of Albumin, Transferrin, Transthyretin, Asialoglycoprotein Receptor, Cytochrome P450 Isoform, Uptake Transporter, and Efflux Transporter Genes as a Function of Culture Duration in Prolonged Cultured Cryopreserved Human Hepatocytes as Collagen-Matrigel Sandwich Cultures: Evidence for Redifferentiation upon Prolonged Culturing.

Drug metabolism and disposition: the biological fate of chemicals·2021
Same author

3D cell culture models: Drug pharmacokinetics, safety assessment, and regulatory consideration.

Clinical and translational science·2021
Same author

Prolonged cultured human hepatocytes as an in vitro experimental system for the evaluation of potency and duration of activity of RNA therapeutics: Demonstration of prolonged duration of gene silencing effects of a GalNAc-conjugated human hypoxanthine phosphoribosyl transferase (HPRT1) siRNA.

Biochemical pharmacology·2020
Same journal

From biologics to small-molecule modulators: The evolving landscape of interleukin-targeted therapeutics.

Drug discovery today·2026
Same journal

Targeting the GLP-1 receptor pathways for dual management of obesity and depression.

Drug discovery today·2026
Same journal

Chemical intervention strategies targeting MYC for cancer therapy.

Drug discovery today·2026
Same journal

How many protein pairs can we chemically target?

Drug discovery today·2026
Same journal

From trial-and-error to inverse design: how AI is redefining drug delivery systems.

Drug discovery today·2026
Same journal

Critical evaluation of the key mediators causing life-threatening symptoms during human anaphylaxis.

Drug discovery today·2026
See all related articles

This summit explored technologies to speed up drug discovery and development. Key focus areas included innovative methods to advance drug candidates from initial concept to market-ready treatments efficiently.

Area of Science:

  • Pharmacology
  • Biotechnology
  • Drug Development

Background:

  • The drug discovery and development pipeline is lengthy and costly.
  • There is a continuous need for innovative technologies to accelerate this process.
  • The 2002 International Drug Discovery and Development Summit addressed these challenges.

Purpose of the Study:

  • To discuss technologies that can expedite the journey from a drug lead to a final drug product.
  • To foster collaboration and knowledge sharing among experts in drug discovery and development.
  • To identify key trends and future directions in pharmaceutical R&D.

Main Methods:

  • The summit featured presentations and discussions on cutting-edge technologies.
  • Case studies and expert panels highlighted successful and emerging approaches.

Related Experiment Videos

  • Focus was placed on integrating novel methodologies into the drug development workflow.

    • Main Results:

    • Identification of several key technologies with the potential to significantly shorten drug development timelines.
    • Emphasis on the importance of early-stage optimization and predictive modeling.
    • Discussion on regulatory considerations and their impact on accelerated development.

    Conclusions:

    • Accelerating drug development requires a multi-faceted approach, integrating novel technologies and strategic planning.
    • The summit provided a platform for advancing the understanding and application of speed-enhancing innovations.
    • Continued research and development in targeted technologies are crucial for future pharmaceutical advancements.